First case of mixed infection with Cryptococcus deuterogattii and Cryptococcus neoformans VNI in an Ivorian HIV-positive patient

INTRODUCTIONCryptococcal meningitis (CM) may be caused by several species of Cryptococcus. CASE PRESENTATIONWe describe a fatal case of CM in a HIV-positive patient from Ivory Coast infected by Cryptococcus neoformans VNI and Cryptococcusdeuterogattii. Isolates were recovered from cerebrospinal flui...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JMM case reports 2016, Vol.3 (4), p.e005037-e005037
Hauptverfasser: Kassi, Fulgence K, Bellet, Virginie, Doumbia, Adama, Krasteva, Donika, Drakulovski, Pascal, Kouakou, Gisèle A, Gatchitch, François, Delaporte, Eric, Reynes, Jacques, Mallié, Michèle, Menan, Hervé I E, Bertout, Sébastien
Format: Report
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:INTRODUCTIONCryptococcal meningitis (CM) may be caused by several species of Cryptococcus. CASE PRESENTATIONWe describe a fatal case of CM in a HIV-positive patient from Ivory Coast infected by Cryptococcus neoformans VNI and Cryptococcusdeuterogattii. Isolates were recovered from cerebrospinal fluid (CSF) prior to systemic antifungal treatment. Six isolates were studied (the entire culture plus five isolated colonies from it). Serotyping was performed via LAC 1 and CAP 64 gene amplification. Genotyping was performed using restriction fragment length polymorphism (RFLP) analysis of the URA5 gene, (GACA)4, (GTG)5 and M13 PCR fingerprinting. URA5-RFLP analysis identified the original culture with two different molecular type combinations. However, URA5-RFLP profiles of the five colonies isolated from the original sample revealed two different species. Four colonies were identified as C.deuterogattii and the last isolate as C.neoformans VNI. The in vitro susceptibility profile was determined using the standard method according to the CLSI M27-A3 protocol. The isolates were susceptible to the tested antifungals (fluconazole, flucytosine and amphotericin B). Treatment with fluconazole (1200  mg day-1) was initiated; however, the patient died 17 days after the onset of antifungal therapy. CONCLUSIONThis is the first reported case of mixed infection with C. neoformans and C.deuterogattii in a HIV-positive patient.
ISSN:2053-3721
2053-3721
DOI:10.1099/jmmcr.0.005037